Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05829590
Other study ID # EA-23-002
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date May 15, 2023
Est. completion date July 31, 2023

Study information

Verified date March 2023
Source Renmin Hospital of Wuhan University
Contact Honggang Yu, MD
Phone 13871281899
Email yuhonggang1969@163.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In this study, the investigators proposed a prospective study about the effectiveness of speech and image recognition-based system in improving reporting quality during colonoscopy for colonoscopy report quality in endoscopists. The participants would be divided into two groups. For the collected colonoscopy videos, group A would record their observations with the assistance of the artificial intelligence system. The artificial intelligence assistant system can automatically capture bowel segment images and prompt abnormal lesions. Group B would complete the endoscopy report without special prompts. After a period of washout period, the two groups switched, that is, group A without AI assistance and group B with AI assistance to complete the colonoscopy report. Then, the completeness of the colonoscopy report, the completeness of capturing anatomical landmarks and detected lesions, the completeness of structured description, the accuracy of lesion reporting, the time for reporting and the satisfaction with the reporting system are compared with or without AI assistance.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 10
Est. completion date July 31, 2023
Est. primary completion date June 15, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: Patients: 1. Male or female =18 years old; 2. Able to read, understand and sign an informed consent; 3. The investigator believes that the subjects can understand the process of the clinical study, are willing and able to complete all study procedures and follow-up visits, and cooperate with the study procedures; 4. Patients requiring colonoscopy. Doctors: 1. Males or females who are over 18 years old; 2. After qualified medical education and obtaining the Physician's Practice License. Exclusion Criteria: Patients: 1. Have drug or alcohol abuse or mental disorder in the last 5 years; 2. Pregnant or lactating women; 3. Patients with known multiple polyp syndrome; 4. patients with known inflammatory bowel disease; 5. known intestinal stenosis or space-occupying tumor; 6. known colon obstruction or perforation; 7. patients with a history of colorectal surgery; 8. Patients with a previous history of allergy to pre-used spasmolysis; 9. Unable to perform biopsy due to coagulation disorders or oral anticoagulants; 10. High-risk diseases or other special conditions that the investigator considers the subject unsuitable for participation in the clinical trial. Doctors: 1. The researcher believes that the subjects are not suitable for participating in clinical trials.

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Artificial intelligence assistant system
The artificial intelligence assistant system can automatically capture bowel segment images and prompt abnormal lesions based on speech recognition and deep learning.

Locations

Country Name City State
China Renmin Hospital of Wuhan Univercity Wuhan Hubei

Sponsors (1)

Lead Sponsor Collaborator
Renmin Hospital of Wuhan University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Other The integrity of report lesion Report lesion integrity with or without AI-assisted. Calculation method = number of report lesions / total number of lesions x 100% One month
Other The completeness of structured description The completeness of structured description with or without AI-assisted. Calculation method = number of structured descriptions / total number of structured descriptions need to record x 100% One month
Other Accuracy of lesion reporting Accuracy of lesion report with or without AI-assisted. Calculation method = number of lesions with correct description / total number of lesions descriptionx 100% One month
Other The time for reporting The time for reporting with or without AI-assisted One month
Other The satisfaction with the reporting system The satisfaction with the reporting system with or without AI-assisted One month
Primary The integrity of colonoscopy report Report integrity with or without AI-assisted. Calculation method = number of information recorded / total number of information need to record x 100% One month
Secondary The integrity of capturing anatomical landmarks The integrity in captured bowel landmrak images with or without AI-assisted. Calculation method = number of anatomical landmarks in captured images / total number of anatomical landmarks x 100% One month
See also
  Status Clinical Trial Phase
Completed NCT04101097 - Training and Validation of Models of Factors to Predict Inadequate Bowel Preparation Colonoscopy
Completed NCT03247595 - Testing How Well Magnesium Citrate Capsules Work as Preparation for a Colonoscopy N/A
Completed NCT04214301 - An Open-Label Preference Evaluation of BLI800 Phase 4
Withdrawn NCT05754255 - Comparison of High-flow Oxygen With or Without Nasal Positive Airway Pressure (PAP) During Propofol Sedation for Colonoscopy in an Ambulatory Surgical Center N/A
Recruiting NCT02484105 - Comforting Conversation During Colonoscopy: A Trial on Patient Satisfaction Phase 4
Active, not recruiting NCT02264249 - Residual Gastric Volume in Same Day Versus Split Dose and Evening Before Bowel Preparation N/A
Terminated NCT01978509 - The Affect of Low-Volume Bowel Preparation for Hospitalized Patients Colonoscopies N/A
Completed NCT01964417 - The Comparative Study Between Bowel Preparation Method Phase 3
Recruiting NCT01685970 - Comparison of Same-day 2 Sachets Picosulfate Versus High Volume PEG for Afternoon Colonoscopy Phase 3
Completed NCT01518790 - Short Course, Single-dose PEG 3350 for Colonoscopy Prep in Children N/A
Recruiting NCT00748293 - Achievement of Better Examinee Compliance on Colon Cleansing Using Commercialized Low-Residue Diet N/A
Completed NCT00779649 - MoviPrep® Versus HalfLytely®, Low-VolUme PEG Solutions for Colon Cleansing: An InvesTigator-blindEd, Randomized, Trial Phase 4
Completed NCT00671177 - Clinical Evaluation of Water Immersion Colonoscopy Insertion Technique N/A
Completed NCT00380497 - Pico-Salax Versus Poly-Ethylene Glycol for Bowel Cleanout Before Colonoscopy in Children Phase 4
Recruiting NCT00160823 - Impact of a Self-Administered Information Leaflet on Adequacy of Colonic Cleansing for in-Hospital Patients Phase 3
Completed NCT00314418 - Patient Position and Impact on Colonoscopy Time N/A
Completed NCT00390598 - PEG Solution (Laxabon®) 4L Versus Senna Glycoside (Pursennid® Ex-Lax) 36mg and PEG Solution (Laxabon®) 2L for Large Bowel Cleansing Prior to Colonoscopy Phase 2/Phase 3
Completed NCT00209573 - A Study of AQUAVAN® Injection Versus Midazolam HCl for Sedation in Patients Undergoing Elective Colonoscopy Phase 3
Completed NCT00427089 - Comparison of 2L NRL994 With NaP Preparation in Colon Cleansing Prior to Colonoscopies for Colon Tumor Screening Phase 3
Completed NCT05823350 - The Effect of Abdominal Massage on Pain and Distention After Colonoscopy N/A